Risk Evaluation and Management in Heart Failure

Launched by RUIJIN HOSPITAL · Dec 19, 2016

Keywords

ClinConnect Summary

This clinical trial, titled "Risk Evaluation and Management in Heart Failure," is exploring how different risk factors related to cardiovascular health, like lifestyle choices and specific health indicators, can affect the outcomes for people with heart failure. The study is being conducted with patients in China and aims to understand how these factors might influence the overall health and recovery of individuals suffering from heart failure.

To be eligible for this study, participants must be at least 18 years old and currently hospitalized with certain heart conditions, such as congestive heart failure or cardiogenic shock, and diagnosed with impaired heart function through an ultrasound test. They also need to be able to give their consent to participate. If you join the study, you'll be asked to share information about your health and undergo follow-up visits to monitor your condition. This trial is currently recruiting participants of all genders, and it's an important opportunity to contribute to research that could improve heart failure management in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • aged 18 and above
• * inpatient with one of the following clinical situations:
• • congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema)
• • cardiogenic shock
• • Insufficient high output cardiac
• • with impaired cardiac function diagnosed by echocardiography
• • able to provide informed consent
• Exclusion Criteria:
• • expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months